Recall events
/
Event 86940
Event summary
Timeline bucket December 07, 2020
Product types Drug
Classifications Class I and Class II
Statuses Terminated
Recalling firm wording AVKARE Inc.
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
2 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 2
Sildenafil Tablets USP 100 mg, Rx Only, 100-count Bottle, Manufactured for: AvKARE Pulaski, TN 38478, NDC 42291-748-01.
D-0167-2021
Recall number D-0167-2021
Initiated December 07, 2020
Classification Class II
Status Terminated
Quantity 38715 bottles
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.
Code information Lot: 36884 Exp. 03/2022
Distribution pattern Nationwide within the U.S.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12330]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 2
TraZODONE Hydrochloride Tablets USP 100 mg, Rx Only, 1000-count Bottle, Manufactured for: AvKARE Pulaski, TN 38478, NDC 42291-834-10
D-0168-2021
Recall number D-0168-2021
Initiated December 07, 2020
Classification Class I
Status Terminated
Quantity 14368 bottles
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.
Code information Lot: 36783 Exp. 06/2022
Distribution pattern Nationwide within the U.S.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12417]
FDA event record
· Exact recall-number query on openFDA